Frontiers in cell and developmental biology
Correction: Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma.
Wuyang Yun, Yuyu Li, Yanlei Ge, Xiaoyun Zhang, Huifeng Liu, Wen Chen, Li Xiao
Published: 202510.3389/fcell.2025.1728870
Abstract
Open Access[This corrects the article DOI: 10.3389/fcell.2025.1639922.].